Aplastic anemia in the elderly a nationwide survey

  • Slides: 8
Download presentation
Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia by Adrien Contejean, Matthieu Resche-Rigon, Jérôme Tamburini, Marion Alcantara, Fabrice Jardin, Etienne Lengliné, Lionel Adès, Didier Bouscary, Ambroise Marçais, Delphine Lebon, Cécile Chabrot, Louis Terriou, Fiorenza Barraco, Anne Banos, Lucile Bussot, Jean-Yves Cahn, Pierre Hirsch, Natacha Maillard, Laurence Simon, Luc-Matthieu Fornecker, Gerard Socié, Regis Peffault de Latour, and Flore Sicre de Fontbrune haematol Volume 104(2): 256 -262 January 31, 2019 © 2019 by Ferrata Storti Foundation

Population characteristics at diagnosis (n=88). Adrien Contejean et al. Haematologica 2019; 104: 256 -262

Population characteristics at diagnosis (n=88). Adrien Contejean et al. Haematologica 2019; 104: 256 -262 © 2019 by Ferrata Storti Foundation

Population characteristics according to first-line treatment (n=88). Adrien Contejean et al. Haematologica 2019; 104:

Population characteristics according to first-line treatment (n=88). Adrien Contejean et al. Haematologica 2019; 104: 256 -262 © 2019 by Ferrata Storti Foundation

Impact of treatment on outcome (overall response and mortality) after adjustment for treatment line,

Impact of treatment on outcome (overall response and mortality) after adjustment for treatment line, disease severity and performance status. Adrien Contejean et al. Haematologica 2019; 104: 256 -262 © 2019 by Ferrata Storti Foundation

Impact of treatment on overall response, after adjustment for treatment line, disease severity and

Impact of treatment on overall response, after adjustment for treatment line, disease severity and performance status (multivariable analysis, with ATG-Cs. A as a baseline). Adrien Contejean et al. Haematologica 2019; 104: 256 -262 © 2019 by Ferrata Storti Foundation

Treatment tolerance comparing ATG-Cs. A regimens with others. Adrien Contejean et al. Haematologica 2019;

Treatment tolerance comparing ATG-Cs. A regimens with others. Adrien Contejean et al. Haematologica 2019; 104: 256 -262 © 2019 by Ferrata Storti Foundation

Overall survival. Adrien Contejean et al. Haematologica 2019; 104: 256 -262 © 2019 by

Overall survival. Adrien Contejean et al. Haematologica 2019; 104: 256 -262 © 2019 by Ferrata Storti Foundation

Impact of baseline characteristics on mortality. Adrien Contejean et al. Haematologica 2019; 104: 256

Impact of baseline characteristics on mortality. Adrien Contejean et al. Haematologica 2019; 104: 256 -262 © 2019 by Ferrata Storti Foundation